NuGenerex Immuno-Oncology Secures $535M Valuation
22 Jun 2021 //
GLOBENEWSWIRE
Generex and NuGenerex Immuno-Oncology Ii-Key-SARS-CoV-2 Vaccine Partner
23 Nov 2020 //
GLOBENEWSWIRE
NuGenerex Immuno-Oncology Announces Closing of a Licensing Agreement
07 Oct 2020 //
NASDAQ